Trademarkia Logo

United Kingdom

£
Trademark Search
RYBLOZEL

View On IPO.GOV.UK

Registered

on 14 Feb 2017

Last Applicant/ Owned by

Celgene Corporation

86 Morris Avenue Summit NJ 07901

, ,

Serial Number

UK00801344056 filed on 14th Feb 2017

Registration Number

UK00801344056 registered on
13th Oct 2017

Correspondent Information

Sipara Limited

Rochester House, Eynsham Road, Farmoor

Oxford,

OX2 9NH

RYBLOZEL

pharmaceutical preparations for use in the treatment of beta thalassemia and myelodysplastic syndromes, autoinflammatory disease, autoimmune disease, Read More

Classification Information

Class [5]
Pharmaceutical Products

Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodysplastic syndromes, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system.

Mark Details

Serial Number

UK00801344056

Mark Type

Word

Kind of mark

Individual